.

Deeper Knowledge, Faster

  • Find suppliers and generic API sources
  • Obtain formulation and manufacturing information
  • Set up watchlists for daily email updates

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Deloitte
Farmers Insurance
Novartis
Queensland Health
Johnson and Johnson
Mallinckrodt
Teva
Accenture
Fish and Richardson
Baxter

Generated: June 26, 2017

DrugPatentWatch Database Preview

EZETIMIBE Drug Profile

« Back to Dashboard

What is the patent landscape for Ezetimibe, and when can generic versions of Ezetimibe launch?

Ezetimibe is a drug marketed by Amneal Pharms Co, Ohm Labs Inc, Teva Pharms Usa, Sandoz Inc, Watson Labs Inc, Zydus Pharms Usa Inc, Apotex Inc, Glenmark Pharms Ltd, Watson Labs Teva, Dr Reddys Labs Sa, and Impax Labs Inc. and is included in twelve NDAs.

The generic ingredient in EZETIMIBE is ezetimibe; simvastatin. There are twenty-four drug master file entries for this compound. Nine suppliers are listed for this compound. There are five tentative approvals for this compound. Additional details are available on the ezetimibe; simvastatin profile page.

Summary for Tradename: EZETIMIBE

Patents:0
Applicants:11
NDAs:12
Suppliers / Packagers: see list9
Bulk Api Vendors: see list61
Clinical Trials: see list241
Patent Applications: see list4,484
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:EZETIMIBE at DailyMed

Pharmacology for Tradename: EZETIMIBE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Amneal Pharms Co
EZETIMIBE
ezetimibe
TABLET;ORAL208803-001Jun 12, 2017ABRXNoNo► Subscribe► Subscribe
Watson Labs Inc
EZETIMIBE AND SIMVASTATIN
ezetimibe; simvastatin
TABLET;ORAL202968-002Apr 26, 2017ABRXNoNo► Subscribe► Subscribe
Impax Labs Inc
EZETIMIBE AND SIMVASTATIN
ezetimibe; simvastatin
TABLET;ORAL201890-004Apr 26, 2017ABRXNoNo► Subscribe► Subscribe
Apotex Inc
EZETIMIBE
ezetimibe
TABLET;ORAL208332-001Jun 12, 2017ABRXNoNo► Subscribe► Subscribe
Sandoz Inc
EZETIMIBE
ezetimibe
TABLET;ORAL203931-001Jun 12, 2017ABRXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Moodys
Harvard Business School
Healthtrust
Federal Trade Commission
Chubb
Novartis
Cerilliant
Dow
Fish and Richardson
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot